Abstract
SB743921 is a potent inhibitor of the spindle protein kinesin and is being investigated in ongoing clinical trials for the treatment of myeloma. However, little is known about the molecular events underlying the induction of cell death in multiple myeloma (MM) by SB743921, alone or in combination treatment. Here, we report that SB743921 induces mitochondria-mediated cell death via inhibition of the NF-κB signaling pathway, but does not cause cell cycle arrest in KMS20 MM cells. SB743921-mediated inhibition of the NF-κB pathway results in reduced expression of SOD2 and Mcl-1, leading to mitochondrial dysfunction. We also found that combination treatment with SB743921 and bortezomib induces death in bortezomib-resistant KMS20 cells. Altogether, these data suggest that treatment with SB743921 alone or in combination with bortezomib offers excellent translational potential and promises to be a novel MM therapy.
References
Mar 23, 1990·Cell·A P Enos, N R Morris
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·K E Sawin, T J Mitchison
Jan 1, 1997·Annual Review of Cell and Developmental Biology·R D Vale, R J Fletterick
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Guolin TanGuiyuan Li
Oct 19, 2002·Radiation Research·Min-Jeong YiYun-Sil Lee
Jun 26, 2004·Blood·Dharminder ChauhanKenneth C Anderson
Oct 29, 2004·The New England Journal of Medicine·Robert A Kyle, S Vincent Rajkumar
Aug 16, 2005·Blood·Sagar LonialUNKNOWN SUMMIT/CREST Investigators
Jan 13, 2006·The Oncologist·Jesús San MiguelHeinz Ludwig
Mar 6, 2007·Journal of the National Comprehensive Cancer Network : JNCCN·Paul G RichardsonKenneth C Anderson
Jan 29, 2008·Current Cancer Drug Targets·M-A EstèveD Braguer
Nov 29, 2008·The Lancet Oncology·Enrique M OcioJesús F San-Miguel
Apr 1, 2008·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Pil-Jae KongSung-Soo Kim
Mar 23, 2012·Immunological Reviews·Joseph A DiDonatoMichael Karin
Mar 7, 2013·International Journal of Cancer. Journal International Du Cancer·I S SongJ Han
Jul 24, 2013·Journal of Medicinal Chemistry·Sandeep K TalapatraFrank Kozielski
Oct 26, 2013·Experimental & Molecular Medicine·In-Sung SongJin Han
Nov 22, 2013·BMB Reports·Hong XieYingyu Chen
Nov 30, 2013·BMB Reports·Juwon ParkSung-Soo Yoon
Nov 30, 2013·BMB Reports·Su-jian LiuJi-dong Wu
Citations
Sep 3, 2020·Cell Death & Disease·Chieh-Ting FangLing-Huei Yih
Feb 27, 2018·Antioxidants & Redox Signaling·Alessia Parascandolo, Mikko O Laukkanen
Jul 6, 2016·Anti-cancer Drugs·Li ZhuYuan Sheng
Aug 29, 2018·Environmental and Molecular Mutagenesis·Xiang WanShao-Chen Sun
Dec 10, 2019·Expert Opinion on Investigational Drugs·Esperanza Macarena AlgarínEnrique M Ocio
Aug 14, 2021·Human Genomics·Enchong ZhangLiping Shan